180 related articles for article (PubMed ID: 22072880)
1. In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.
Lin YM; Wu JY; Chen YC; Su YD; Ke WT; Ho HO; Sheu MT
Int J Nanomedicine; 2011; 6():2445-57. PubMed ID: 22072880
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.
Wei JD; Ho HO; Chen CH; Ke WT; Chen ET; Sheu MT
J Pharm Pharmacol; 2010 Dec; 62(12):1685-96. PubMed ID: 21054394
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
Cho YD; Park YJ
Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
[TBL] [Abstract][Full Text] [Related]
4. Optimized formulation of solid self-microemulsifying sirolimus delivery systems.
Cho W; Kim MS; Kim JS; Park J; Park HJ; Cha KH; Park JS; Hwang SJ
Int J Nanomedicine; 2013; 8():1673-82. PubMed ID: 23641156
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems.
Kim GG; Poudel BK; Marasini N; Lee DW; Hiep TT; Yang KY; Kim JO; Yong CS; Choi HG
Drug Dev Ind Pharm; 2013 Sep; 39(9):1431-8. PubMed ID: 23046292
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
7. Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate.
Bajaj A; Rao MR; Khole I; Munjapara G
Drug Dev Ind Pharm; 2013 May; 39(5):635-45. PubMed ID: 22564007
[TBL] [Abstract][Full Text] [Related]
8. D-α-tocopherol polyethylene glycol 1000 succinate-based microemulsion delivery system: Stability enhancement of physicochemical properties of luteolin.
Zheng Y; Zhao C; Chen B; Teng H; Ai C; Chen L
Food Chem; 2023 Nov; 426():136587. PubMed ID: 37364422
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.
Wang Y; Sun J; Zhang T; Liu H; He F; He Z
Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281
[TBL] [Abstract][Full Text] [Related]
10. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
[TBL] [Abstract][Full Text] [Related]
11. Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235).
Visetvichaporn V; Kim KH; Jung K; Cho YS; Kim DD
Int J Pharm; 2020 Jan; 573():118772. PubMed ID: 31765770
[TBL] [Abstract][Full Text] [Related]
12. Solid self-microemulsifying drug delivery system of ritonavir.
Deshmukh A; Kulkarni S
Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
[TBL] [Abstract][Full Text] [Related]
13. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of the drug distribution and mucus diffusion properties of self-microemulsifying drug delivery systems on the oral absorption of fenofibrate.
Sunazuka Y; Ueda K; Higashi K; Tanaka Y; Moribe K
Int J Pharm; 2018 Jul; 546(1-2):263-271. PubMed ID: 29763688
[TBL] [Abstract][Full Text] [Related]
15. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
Ke WT; Lin SY; Ho HO; Sheu MT
J Control Release; 2005 Feb; 102(2):489-507. PubMed ID: 15653166
[TBL] [Abstract][Full Text] [Related]
16. Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design.
Yeom DW; Song YS; Kim SR; Lee SG; Kang MH; Lee S; Choi YW
Int J Nanomedicine; 2015; 10():3865-77. PubMed ID: 26089663
[TBL] [Abstract][Full Text] [Related]
17. Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system.
Chen ZQ; Liu Y; Zhao JH; Wang L; Feng NP
Int J Nanomedicine; 2012; 7():1115-25. PubMed ID: 22403491
[TBL] [Abstract][Full Text] [Related]
18. Development of solidified self-microemulsifying drug delivery systems containing l-tetrahydropalmatine: Design of experiment approach and bioavailability comparison.
Tung NT; Tran CS; Pham TM; Nguyen HA; Nguyen TL; Chi SC; Nguyen DD; Bui TB
Int J Pharm; 2018 Feb; 537(1-2):9-21. PubMed ID: 29246439
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Pharmacokinetics Evaluation of Solid Self-Microemulsifying Drug Delivery System (S-SMEDDS) of Osthole.
Sun C; Gui Y; Hu R; Chen J; Wang B; Guo Y; Lu W; Nie X; Shen Q; Gao S; Fang W
AAPS PharmSciTech; 2018 Jul; 19(5):2301-2310. PubMed ID: 29845504
[TBL] [Abstract][Full Text] [Related]
20. Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate.
Kamboj S; Rana V
Int J Pharm; 2016 Mar; 501(1-2):311-25. PubMed ID: 26854426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
